Most randomized studies on revascularization in stable coronary artery disease exclude left main coronary artery disease (LMCAD). One example of this was the ISCHEMIA study. However, the benefits of functional lesion assessment, as demonstrated in the FAME studies, highlight the importance of this tool in guiding decisions regarding revascularization. Nevertheless, the clinical outcomes of patients...
Individual randomized studies have shown variable results regarding the mortality risk following treatment of left main coronary artery disease (LMCAD), either through percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). However, upon assessment of the latest meta-analyses (with matched data), similar risks of all-cause and cardiovascular mortality have been reported for both groups....
A lesion ≥50% in the left main coronary artery (LMCA) is considered severe, according to various scientific societies, regardless of the presence of symptoms or ischemia, due to the extent of myocardium at risk. In such cases, revascularization is indicated. In many patients, lesions in this section of the coronary artery have severe calcification, which...
The Left main coronary artery supplies circulation to roughly 70% of myocardium, and left main disease requires a high risk intervention with significant impact on patient prognosis. The current guidelines have set the threshold for intervention in LM disease at ≥50% stenosis, irrespective of the presence of symptoms or ischemic burden. LM calcification is an...
✔️ SOLACI-SBHCI 2023 – International Live Case | INTRAVASCULAR IMAGING & Angio-based Physiology guided complex LEFT MAIN BIFURCATION ✔️ Site: Nanjing First Hospital, Nanjing, China ✔️ August 4, 2023, Copacabana Room, Windsor Oceánico
✔️ SOLACI-SBHCI 2023 – Internationl Live Case | Left Main PCI with Dedicated DES Guided by HD Imaging ✔️ Site: LEIPZIG HEART CENTER – LEIPZIG, GERMANY ✔️ August 3, 2023, Copacabana Room, Windsor Oceánico
Most randomized studies on decision-making in coronary artery disease revascularization exclude left main coronary artery disease (LMCAD), as did the ISCHEMIA Study. On the other hand, the benefits of functionally assessing lesions, proven in studies such as FAME, emphasize the importance of this tool in guiding revascularization decisions. However, there is still little understanding of...
Lesions in the left main coronary artery (LMCA) continue to pose a significant challenge. The use of coronary imaging before percutaneous coronary implantation (PCI) has proven useful in analyzing the lesion, identifying the presence and location of calcification, and determining lesion length in the LMCA, the left anterior descending artery, and the circumflex artery. Various...
You can now relive our virtual event on Are You Ready for Left Main? on our YouTube channel. The event was held through the LATAM Bif-SOLACI Group, had the support of Terumo, and had the invaluable presence of Dr. Goran Stankovic (SRB), among other prominent experts from Latin America. Watch the full video below. 🚀...
LATAM Bif and SOLACI invite you to participate in a new free virtual event on LEFT MAIN, with the presence of a prominent international guest: Dr. Goran Stankovic (SRB). The event has a high-level scientific program and will also have the presence of important members of the LATAM Bif-SOLACIg Registry.